Enova (NYSE: ENVA) chair sells 33,060 shares after exercising options
Rhea-AI Filing Summary
Enova International Executive Chairman David Fisher exercised stock options and sold shares in a combined transaction. He exercised options to acquire 33,060 shares of common stock at an exercise price of $20.73 per share, then sold 33,060 shares in an open-market sale at a weighted average price of $199.0514 per share, with individual trades executed between $193.85 and $202.70. Following these transactions, he directly holds 306,444 shares of Enova International common stock.
Positive
- None.
Negative
- None.
Insights
Exercise-and-sell pattern where the chair monetizes options but retains a sizable stake.
Executive Chairman David Fisher exercised options for 33,060 Enova shares at an exercise price of $20.73, then sold the same number of shares at a weighted average of $199.0514. The derivative entry shows a non-qualified stock option with expiration on February 11, 2027.
This is a classic exercise-and-sell sequence, turning an existing option award into cash rather than an open-market share purchase. After selling, Fisher still holds 306,444 common shares directly, indicating continued equity exposure. The sale price range of $193.85–$202.70 shows execution across multiple trades on the same date.
Insider Trade Summary 10b5-1
Net Seller: 33,060 shares ($6,580,639)
Net Sell
3 txns
Insider
Fisher David
Role
Executive Chairman
Sold
33,060 shs ($6.58M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 33,060 | $0.00 | -- |
| Exercise | Common stock, par value $0.00001 per share | 33,060 | $20.73 | $685K |
| Sale | Common stock, par value $0.00001 per share | 33,060 | $199.0514 | $6.58M |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) with limited SAR — 213,182 shares (Direct);
Common stock, par value $0.00001 per share — 339,504 shares (Direct)
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $193.85 to $202.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Key Figures
Shares sold: 33,060 shares
Weighted average sale price: $199.0514 per share
Options exercised: 33,060 options
+4 more
7 metrics
Shares sold
33,060 shares
Open-market sale of common stock on June 17, 2026
Weighted average sale price
$199.0514 per share
Aggregate price for 33,060 shares sold; trades $193.85–$202.70
Options exercised
33,060 options
Non-qualified stock option exercised into common stock
Option exercise price
$20.73 per share
Strike price of non-qualified stock option exercised
Post-transaction holdings
306,444 shares
Common shares directly owned after transactions
Option expiration date
February 11, 2027
Expiration for the non-qualified stock option before exercise
Net share change
33,060 shares net sold
Net buy-sell direction shown as net-sell in summary
Key Terms
Non-Qualified Stock Option, stock appreciation right, Change in Control, tender offer, +2 more
6 terms
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy) with limited SAR"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
stock appreciation right financial
"The limited stock appreciation right ("SAR") and employee stock option were granted in tandem."
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
Change in Control regulatory
"only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
tender offer regulatory
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
exchange offer regulatory
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer"
An exchange offer is a proposal where a company asks investors to swap existing securities, like bonds or shares, for new ones, often with different terms or maturity dates. It matters to investors because it can affect the value of their holdings and the company's financial strategy, potentially providing benefits like better interest rates or reduced debt.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Enova (ENVA) Executive Chairman David Fisher do in this Form 4?
David Fisher exercised stock options for 33,060 Enova shares and sold 33,060 shares in the open market. The exercise converted options into common stock, which was then sold, while he continued to hold 306,444 shares directly after the transactions.
What stock options did David Fisher exercise in the Enova (ENVA) Form 4?
He exercised a non-qualified stock option covering 33,060 shares of Enova common stock at an exercise price of $20.73 per share. The option, paired with a limited stock appreciation right, was scheduled to expire on February 11, 2027, according to the disclosed derivative details.
Were David Fisher’s Enova (ENVA) trades executed in one block or multiple trades?
The Form 4 notes that the sale was executed in multiple trades at prices between $193.85 and $202.70. The reported sale price of $199.0514 per share represents the weighted average of those trades, with full trade details available upon request to the issuer or SEC staff.